Sionna Therapeutics SION
NASDAQ SION
$3.70 +0.13 (+3.64%)
At close: Nov 10, 2026 · 4:00 PM EST

Sionna Therapeutics (SION) Preferred Stock Liabilities (2023 - 2024)

Updated

Sionna Therapeutics (SION) reported Preferred Stock Liabilities of $330.37 million for Q4 2024, unchanged from the prior quarter.

Analysis

Sionna Therapeutics (SION) Preferred Stock Liabilities (2023 - 2024) Analysis & Trends

Dating back to Q1 2024, Sionna Therapeutics' Preferred Stock Liabilities record includes 4 quarters.

  • Per Business Quant data, the three quarters before Q4 2024 came in at $330.37 million (Q3 2024), $330.37 million (Q2 2024) and $330.37 million (Q1 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Sionna Therapeutics 167.27 Mn -720.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 330.37 Mn
Sep 30, 2024 330.37 Mn
Jun 30, 2024 330.37 Mn
Mar 31, 2024 330.37 Mn
Dec 31, 2023 149.04 Mn
API Access

Sionna Therapeutics Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=SION&period=max&api_key=YOUR_API_KEY